Buy Midamor, Kaluril, Modamide (Amiloride) diuretic medication
Cheap qualitative Amiloride Hydrochloride 5 mg tablets online
HOW AND WHERE TO BUY AMILORIDE (MIDAMOR, KALURIL, MODAMIDE) 5 MG TABLETS OR CAPSULES ONLINE:
MIDAMOR (AMILORIDE HCL): PRECAUTIONS
Electrolyte Imbalance and BUN Increases
Hyponatremia and hypochloremia may occur when Amiloride Hydrochloride (Midamor) is used with other diuretics and increases in BUN levels have been reported. These increases usually have accompanied vigorous fluid elimination, especially when diuretic therapy was used in seriously ill patients, such as those who had hepatic cirrhosis with ascites and metabolic alkalosis, or those with resistant edema. Therefore, when Midamor is given with other diuretics to such patients, careful monitoring of serum electrolytes and BUN levels is important. In patients with pre-existing severe liver disease, hepatic encephalopathy, manifested by tremors, confusion, and coma, and increased jaundice, have been reported in association with diuretics, including amiloride HCl.
When Amiloride HCl is administered concomitantly with an angiotensin-converting enzyme inhibitor, an angiotensin II receptor antagonist, cyclosporine or tacrolimus, the risk of
hyperkalemia may be increased. Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent
monitoring of serum potassium.
Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity. Read circulars for lithium preparations before use of such concomitant therapy.
In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.
Therefore, when Midamor and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
Since indomethacin and potassium-sparing diuretics, including Midamor (Amiloride), may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.
Carcinogenicity, Mutagenicity, Impairment of Fertility
There was no evidence of a tumorigenic effect when amiloride HCl was administered for 92 weeks to mice at doses up to 10 mg / kg per day (25 times the maximum daily human dose).
Amiloride HCl has also been administered for 104 weeks to male and female rats at doses up to 6 and 8 mg / kg per day (15 and 20 times the maximum daily dose for humans, respectively) and showed no evidence of carcinogenicity.
Midamor (Amiloride HCl) was devoid of mutagenic activity in various strains of Salmonella typhimurium with or without a mammalian liver microsomal activation system (Ames test).
Pregnancy Category B. Teratogenicity studies with amiloride HCl in rabbits and mice given 20 and 25 times the maximum human dose, respectively, revealed no evidence of harm to the fetus, although studies showed that the drug crossed the placenta in modest amounts. Reproduction studies in rats at 20 times the expected maximum daily dose for humans showed no evidence of impaired fertility. At approximately 5 or more times the expected maximum daily dose for humans, some toxicity was seen in adult rats and rabbits and a decrease in rat pup growth and survival occurred.
There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be
used during pregnancy only if clearly needed.
Studies in rats have shown that amiloride is excreted in milk in concentrations higher than those found in blood, but it is not known whether Midamor (Amiloride Hydrochloride) is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Amiloride (Midamor), a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients have not been established.
Clinical studies of Amiloride HCl (Midamor) did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.
This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
Midamor (Amiloride HCl) related pharmaceutical drugs and medications
|Trade name of the drug
||Pharmaceutical forms and doses
|Raunova Plus - Hydrochlorothiazide; Syrosingopine
||N / A
|Epler - Eplerenone
||Tablets; Oral; Eplerenone 50 mg
Buy Midamor (Amiloride HCl) Online
Midamor prescribing information
Copyright © Buy Amiloride Online